{"id":"NCT03504852","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis","officialTitle":"A Randomized, Double-blind, Multicenter Study Assessing Short and Long-term Efficacy, Safety, and Tolerability of Sub-cutaneous Secukinumab in Subjects of Body Weight 90 kg or Higher With Moderate to Severe Chronic Plaque-type Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-06-25","primaryCompletion":"2019-09-13","completion":"2020-07-15","firstPosted":"2018-04-20","resultsPosted":"2021-06-07","lastUpdate":"2021-10-11"},"enrollment":331,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"OTHER"},"conditions":["Moderate to Severe Chronic Plaque-type Psoriasis"],"interventions":[{"type":"DRUG","name":"secukinumab 150 mg","otherNames":[]}],"arms":[{"label":"Secukinumab 300 mg every 2 weeks (Q2W)","type":"EXPERIMENTAL"},{"label":"Secukinumab 300 mg every 4 weeks (Q4W)","type":"ACTIVE_COMPARATOR"},{"label":"Secukinumab 300 mg every 4 weeks non-responders up-titration (Q4W NR up)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess secukinumab high dose (every 2 weeks) vs standard dose (every 4 weeks) in heavy body weight subjects with moderate to severe plaque psoriasis.","primaryOutcome":{"measure":"Percentage of Subjects Who Achieve 90% or Greater Reduction in Psoriasis Area and Severity Index (PASI) Score - Week 16 (Full Analysis Set)","timeFrame":"16 weeks","effectByArm":[{"arm":"Secukinumab 300 mg Every 2 Weeks (Q2W)","deltaMin":121,"sd":null},{"arm":"Secukinumab 300 mg Every 4 Weeks (Q4W) (up to Week 16 Pre-dose)","deltaMin":92,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0003"},{"comp":"OG000 vs OG001","p":"0.0003"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":7},"locations":{"siteCount":67,"countries":["United States","Canada","Czechia","Germany","Hungary","Italy","Russia"]},"refs":{"pmids":["34981829"],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=862"]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":165},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Diarrhoea","Headache","Arthralgia"]}}